WBS holder plans sale of 8,000 shares

A shareholder of WBS has given notice of a proposed sale of 8,000 shares of common stock through J.P.

Rhea-AI Filing Summary

A shareholder of WBS has given notice of a proposed sale of 8,000 shares of common stock through J.P. Morgan Securities LLC, with an aggregate market value of 451,440, targeted around 11/17/2025 on the NYSE.

The table notes that 161,290,301 shares of this class were outstanding. The shares to be sold were originally received as stock award compensation directly from the issuer on several dates between 2017 and 2022, with payment described as compensation rather than cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What planned stock sale does the WBS Form 144 disclose?

The notice covers a planned sale of 8,000 shares of WBS common stock. These shares are to be sold through J.P. Morgan Securities LLC on or about 11/17/2025 on the NYSE, with an aggregate market value listed as 451,440.

How were the WBS shares in this Form 144 originally acquired?

The shares were acquired as stock award compensation from the issuer. The table lists multiple awards of common stock between 2017 and 2022, each described as “Stock Award - Compensation,” with payment noted simply as “Compensation,” not cash purchases.

What does the WBS Form 144 say about shares outstanding?

The notice reports that 161,290,301 shares of the relevant class of WBS common stock were outstanding. This figure provides a baseline for understanding the relative size of the planned 8,000-share sale referenced in the securities information table.

Which broker will handle the planned WBS share sale?

The planned sale will be executed through J.P. Morgan Securities LLC, listed at 270 Park Avenue, 10th Floor, New York, NY 10017. This broker is named in the securities information table as handling the 8,000-share transaction on the NYSE.

What representation does the seller make in this WBS Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is part of the standard certification language accompanying the signature section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:20 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001594609
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Webster Financial Corporation
SEC File Number	001-31486
Address of Issuer	200 Elm Street Stamford CONNECTICUT 06902
Phone	203-578-2202
Name of Person for Whose Account the Securities are To Be Sold	John R. Ciulla
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue - 10th Floor New York NY 10017	8000	451440	161290301	11/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2021	Stock Award - Compensation	Issuer			992	02/26/2021	Compensation
Common	02/24/2017	Stock Award - Compensation	Issuer			520	02/24/2017	Compensation
Common	02/24/2017	Stock Award - Compensation	Issuer			564	02/24/2017	Compensation
Common	03/02/2022	Stock Award - Compensation	Issuer			3245	03/02/2022	Compensation
Common	03/01/2021	Stock Award - Compensation	Issuer			1423	03/01/2021	Compensation
Common	02/25/2017	Stock Award - Compensation	Issuer			541	02/25/2017	Compensation
Common	03/20/2019	Stock Award - Compensation	Issuer			715	03/20/2019	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact forJohn R. Ciulla
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)